Andere talen Amgen Inc.

Aandelen

AMGN

US0311621009

Farmaceutische producten

Beurs gesloten - Nasdaq Andere beurzen 21:59:23 18-06-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
289,50 ^USD	-0,19%		-0,79%	+11,07%

17/06	Saoedi-Arabië Sluit Meerdere Gezondheidszorgdeals en Partnerschappen op BIO 2025	MT
13/06	Bericht over documentaire van Amgen over slechte cholesterol ingetrokken	RE

Andere talen

Saudi Arabia Signs Multiple Healthcare Deals, Partnerships at BIO 2025	17/06
AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY	16/06
Alert on Amgen documentary about bad cholesterol withdrawn	13/06
Valores destacados al cierre del mercado norteamericano	13/06
AMGEN TO PRESENT AT GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE	05/06
Samsung Bioepis Secures Marketing Approval In Korea For Its Biosimilar To Amgen's Bone Cancer Drug Xgeva	05/06
Amgen Says Imdelltra Reduced Death Risk by 40% in Small Cell Lung Cancer Trial	02/06
Amgen Announces New Interim Results from the Global Phase 3 Dellphi-304 Trial Showing Imdelltra® (Tarlatamab-Llle)	02/06
Amgen's Imdelltra Shows Lower Risk of Death, Other Benefits in Phase 3 Trial	02/06
Imdelltra Significantly Reduced Risk Of Death By 40% In Small Cell Lung Cancer Patients	02/06
Amgen drug cuts small cell lung cancer death risk by 40%	02/06
Sandoz lance ses biosimilaires du dénosumab aux Etats-Unis	02/06
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE	30/05
Health Rounds: Amgen blood platelet booster helps patients who need chemotherapy	30/05
Fresenius' Denosumab-Biosimilar-Kandidaten vor EU-Zulassung	27/05
HyClone Seeks To Quash Amgen's Subpoena Issued In Amgen/Accord Denosumab BPCIA Litigation	22/05
Sanofi to Acquire Vigil Neuroscience for Up to $600 Million	22/05
Regeneron Awarded $407 Million In Amgen Antitrust Suit	22/05
Inside Amgen's Center for Observational Research: Revolutionizing Drug Development for Real-World Impact	20/05
AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE	16/05
Weight-loss drug developers line up to tap lucrative market as competition heats up	16/05
Regeneron Pharmaceuticals : Décision de justice favorable pour Regeneron au détriment d'Amgen	16/05
USA-Les valeurs à suivre à Wall Street (actualisé)	16/05
Bourse : Richemont relance le luxe, Bayer pourrait mettre Monsanto en faillite, Eutelsat publie	16/05
Super, ça va pas trop bien	16/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripten Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Amgen Inc.

Aandelen

AMGN

US0311621009

Farmaceutische producten

Andere talen

Filters